SAIC Motor’s Hengxu Capital unit took part in the latest round for the Legend Capital-backed X-ray system manufacturer following about $43m in earlier funding.

China-based radiology imaging technology developer Nanovision Technology has recieved almost RMB500m ($78m) in series C funding from investors including automotive manufacturer SAIC Motor’s fund-of-funds, Hengxu Capital.

Northern Light Venture Capital, Proxima Ventures and Sherpa Healthcare Partners filled out the participants in the round.

Founded in 2014, Nanovision is developing an X-ray imaging system intended for use in the healthcare, security and industrial areas. It will use the money to advance clinical trials of its computed tomography scanning products, CompoundEye, for…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn